Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.940
-0.090 (-2.23%)
At close: Dec 5, 2025, 4:00 PM EST
3.830
-0.110 (-2.79%)
After-hours: Dec 5, 2025, 7:54 PM EST
Apyx Medical Market Cap
Apyx Medical has a market cap or net worth of $161.66 million as of December 5, 2025. Its market cap has increased by 264.91% in one year.
Market Cap
161.66M
Enterprise Value
175.73M
1-Year Change
264.91%
Ranking
Category
Stock Price
$3.94
Market Cap Chart
Since February 22, 1999, Apyx Medical's market cap has increased from $10.20M to $161.66M, an increase of 1,484.87%. That is a compound annual growth rate of 10.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 150.70M | 175.50% |
| Dec 31, 2024 | 54.70M | -39.76% |
| Dec 29, 2023 | 90.80M | 12.10% |
| Dec 30, 2022 | 81.00M | -81.60% |
| Dec 31, 2021 | 440.30M | 78.40% |
| Dec 31, 2020 | 246.80M | -14.63% |
| Dec 31, 2019 | 289.10M | 34.34% |
| Dec 31, 2018 | 215.20M | 151.99% |
| Dec 29, 2017 | 85.40M | -13.12% |
| Dec 30, 2016 | 98.30M | 72.15% |
| Dec 31, 2015 | 57.10M | -13.62% |
| Dec 31, 2014 | 66.10M | 72.58% |
| Dec 31, 2013 | 38.30M | -10.93% |
| Dec 31, 2012 | 43.00M | 14.36% |
| Dec 30, 2011 | 37.60M | -35.28% |
| Dec 31, 2010 | 58.10M | -56.48% |
| Dec 31, 2009 | 133.50M | 31.92% |
| Dec 31, 2008 | 101.20M | 2.64% |
| Dec 31, 2007 | 98.60M | -26.20% |
| Dec 29, 2006 | 133.60M | 221.93% |
| Dec 30, 2005 | 41.50M | 17.90% |
| Dec 31, 2004 | 35.20M | -12.87% |
| Dec 31, 2003 | 40.40M | 213.18% |
| Dec 31, 2002 | 12.90M | 21.70% |
| Dec 31, 2001 | 10.60M | 30.86% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |